Sergey Terushkin, MD, FACS , a board-certified bariatric surgeon with extensive expertise in GLP-1 medical weight loss
A recent Survey of Ophthalmology review synthesized findings from cardiovascular outcomes trials, retrospective database analyses, meta-analyses and preclinical studies involving semaglutide, liraglutide, dulaglutide and related agents across six ocular conditions: diabetic retinopathy (DR), glaucoma, nonarteritic anterior ischemic optic neuropathy (NAION), age-related macular degeneration (AMD), idiopathic intracranial hypertension (IIH) and dry eye disease (DED)
As a member of the IGFBP family, IGFBP-4 influences the inflammatory regulation of the tumor microenvironment
ALC is known to help neurological systems and there is considerable research showing it to help cognitive function, mood, energy and endocrine levels
Side effects charts can show whether redness, itching, swelling, or bruising happens more often with a certain site or dose
The implication is that medication and/or drop in visceral adipose tissue greatly improved his insulin sensitivity Lower panel CGM on same patient 12 months later taking GLP-1 mimetic injection weekly